Tags

Type your tag names separated by a space and hit enter

The Risks of Prescribing Hydroxychloroquine for Treatment of COVID-19-First, Do No Harm.
JAMA Intern Med. 2020 Apr 29 [Online ahead of print]JIM

Authors+Show Affiliations

Department of Medicine, University of California, San Francisco.Department of Medicine, University of California, San Francisco.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32347894

Citation

DeJong, Colette, and Robert M. Wachter. "The Risks of Prescribing Hydroxychloroquine for Treatment of COVID-19-First, Do No Harm." JAMA Internal Medicine, 2020.
DeJong C, Wachter RM. The Risks of Prescribing Hydroxychloroquine for Treatment of COVID-19-First, Do No Harm. JAMA Intern Med. 2020.
DeJong, C., & Wachter, R. M. (2020). The Risks of Prescribing Hydroxychloroquine for Treatment of COVID-19-First, Do No Harm. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2020.1853
DeJong C, Wachter RM. The Risks of Prescribing Hydroxychloroquine for Treatment of COVID-19-First, Do No Harm. JAMA Intern Med. 2020 Apr 29; PubMed PMID: 32347894.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The Risks of Prescribing Hydroxychloroquine for Treatment of COVID-19-First, Do No Harm. AU - DeJong,Colette, AU - Wachter,Robert M, Y1 - 2020/04/29/ PY - 2020/4/30/entrez PY - 2020/4/30/pubmed PY - 2020/4/30/medline JF - JAMA internal medicine JO - JAMA Intern Med SN - 2168-6114 UR - https://www.unboundmedicine.com/medline/citation/32347894/full_citation L2 - https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2020.1853 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.